Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

Fig. 6

Flow cytometry detection of infiltrating immune cells in tumors. A In addition to the panel used in blood, we further detected cytokines secreted by CD68+ macrophages in tumors. B Analysis of tumor-infiltrating immune cells. C Comparative analysis of tumor-infiltrating T cells. D Tumor-infiltrating macrophages and their functional analysis

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us